Andreas Teufel

15.5k total citations · 1 hit paper
184 papers, 6.6k citations indexed

About

Andreas Teufel is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Andreas Teufel has authored 184 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 53 papers in Molecular Biology and 52 papers in Epidemiology. Recurrent topics in Andreas Teufel's work include Liver Disease Diagnosis and Treatment (41 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers) and Liver Disease and Transplantation (18 papers). Andreas Teufel is often cited by papers focused on Liver Disease Diagnosis and Treatment (41 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers) and Liver Disease and Transplantation (18 papers). Andreas Teufel collaborates with scholars based in Germany, United States and Switzerland. Andreas Teufel's co-authors include Peter Riederer, Dietmar Bengel, Armin Heils, Susanne Petri, Klaus‐Peter Lesch, Peter R. Galle, Jens U. Marquardt, R. Schlickeiser, Stephan Kanzler and Heiner Westphal and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Andreas Teufel

174 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Allelic Variation of Human Serotonin Transporter Gene Expression

1996 1.8k citations Andreas Teufel et al. profile →

Peers

Countries citing papers authored by Andreas Teufel

Since Specialization

Citations

This map shows the geographic impact of Andreas Teufel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Teufel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Teufel more than expected).

Fields of papers citing papers by Andreas Teufel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Teufel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Teufel. The network helps show where Andreas Teufel may publish in the future.

Co-authorship network of co-authors of Andreas Teufel

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Teufel. A scholar is included among the top collaborators of Andreas Teufel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Teufel. Andreas Teufel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Digestive cancers: mechanisms, therapeutics and management 2025 ·Signal Transduction and Targeted Therapy ·Tianzuo Zhan, Johannes Betge, Nadine Schulte, (unknown), Michael Hirth, Moying Li, (unknown), (unknown), Andreas Teufel, Matthias Ebert	14
2	Current Trends and Advancements in the Management of Hepatocellular Carcinoma 2024 ·Digestive Diseases ·Andreas Teufel, Masatoshi Kudo, (unknown), (unknown), I. Rodrı́guez, (unknown), Ezequiel Ridruejo, (unknown)	5
3	Evaluation of four chatbots in autoimmune liver disease: A comparative analysis 2024 ·Annals of Hepatology ·(unknown), (unknown), (unknown), (unknown), Heike Bantel, Marcos Girala, Matthias P. Ebert, Florian van Bömmel, Andreas Geier, Andrés Gómez-Aldana, Kevin Yau, Mário Reis Álvares‐da‐Silva, (unknown), Ezequiel Ridruejo, Arndt Weinmann, Andreas Teufel	6
4	Intersektorales Management von Patienten mit unklarer Leberwerterhöhung und nichtalkoholischer Fettlebererkrankung (NAFLD) 2023 ·Zeitschrift für Gastroenterologie ·Andreas Teufel, Andreas Geier, Christoph Sarrazin, Jörn M. Schattenberg, Achim Kautz, Rebecca A. Dorner, (unknown), (unknown), Theodor Baars, (unknown), Dirk Müller‐Wieland, S. Rossol, Christian Trautwein, Frank Tacke, Ali Canbay	1
5	Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study 2023 ·Zeitschrift für Gastroenterologie ·(unknown), (unknown), (unknown), (unknown), Florian P. Reiter, Andreas Teufel, Karin Berger, Enrico N. De Toni, Stefan Munker	0
6	Discovery and study of abrasion behavior in granular shear flow 2022 ·Journal of Mechanics ·Shu‐San Hsiau, Kolumban Hutter, (unknown), Andreas Teufel, (unknown), (unknown)	2
7	Post-COVID-19 Impairment of the Senses of Smell, Taste, Hearing, and Balance 2022 ·Viruses ·Sonja Ludwig, (unknown), (unknown), Frederic Jungbauer, (unknown), (unknown), (unknown), Valentin Held, (unknown), Andreas Teufel, (unknown), Nicole Rotter	20
8	Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers 2022 ·Cancers ·(unknown), Timo Itzel, Matthias P. Ebert, Andreas Teufel	2
9	RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues 2021 ·Molecular Oncology ·Alexander Scheiter, Katja Evert, (unknown), Antonio Cigliano, (unknown), Karolina Müller, (unknown), Hongwei Xu, (unknown), Timo Itzel, (unknown), Andrea Coluccio, (unknown), Andreas Teufel, Christoph Brochhausen, Frank Dombrowski, Xin Chen, Matthias Evert, Diego F. Calvisi, Kirsten Utpatel	12
10	Clinical Decision Support Systems 2021 ·Visceral Medicine ·Andreas Teufel, Harald Binder	11
11	Conventional ultrasound for diagnosis of hepatic steatosis is better than believed 2021 ·Zeitschrift für Gastroenterologie ·Christoph F. Dietrich, Long Shi, Axel Löwe, Yi Dong, Andrej Potthoff, Zeno Spârchez, Andreas Teufel, (unknown), Jonas Koch, R. Graham Barr, Xin‐Wu Cui	17
12	Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer 2020 ·Journal of Clinical Investigation ·Peter Dietrich, (unknown), Valerie Fritz, Tatjana Seitz, (unknown), Alexandra Schambony, Andreas E. Kremer, Claudia Günther, Timo Itzel, Wolfgang E. Thasler, Andreas Teufel, Jonel Trebicka, Arndt Hartmann, Markus F. Neurath, Stephan von Hörsten, Anja‐Katrin Bosserhoff, Claus Hellerbrand	34
13	Autoimmune Hepatitis: a Review of Established and Evolving Treatments 2020 ·Journal of Gastrointestinal and Liver Diseases ·(unknown), Kakharman Yesmembetov, Christoph Antoni, (unknown), Matthias Evert, Matthias P. Ebert, Andreas Teufel	6
14	Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects 2018 ·BMC Cancer ·Stefan Munker, Michael Gerken, (unknown), Claudia Ott, Elisabeth Schnoy, Stefan Fichtner‐Feigl, Philipp Wiggermann, Martin Vogelhuber, Wolfgang Herr, Christian Stroszczynski, Hans J. Schlitt, Matthias Evert, Michael Reng, Monika Klinkhammer‐Schalke, Andreas Teufel	42
15	Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration 2013 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·N Elfimova, Elisabeth Sievers, (unknown), M Kwiecinski, A Noetel, Heike Hunt, Diana Becker, Peter Frommolt, Maria Quasdorff, Hans‐Michael Steffen, Peter Nürnberg, Reinhard Büttner, Andreas Teufel, Hans‐Peter Dienes, Uta Drebber, Margarete Odenthal	29
16	Hepatocyte‐specific deletion of the antiapoptotic protein myeloid cell leukemia‐1 triggers proliferation and hepatocarcinogenesis in mice† 2009 ·Hepatology ·Achim Weber, Regina Boger, Binje Vick, Toni Urbanik, Johannes Haybaeck, Stefan Zoller, Andreas Teufel, Peter H. Krammer, Joseph T. Opferman, Peter R. Galle, Marcus Schuchmann, Mathias Heikenwälder, Henning Schulze‐Bergkamen	95
17	Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis 2009 ·Journal of Clinical Gastroenterology ·Marcus A. Wörns, Arndt Weinmann, (unknown), (unknown), Claudia‐Martina Messow, Henning Schulze‐Bergkamen, Andreas Teufel, Marcus Schuchmann, Stephan Kanzler, Christoph Düber, Gerd Otto, Peter R. Galle	121
18	Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes # 2008 ·Hepatology ·Binje Vick, Achim Weber, Toni Urbanik, T Maass, Andreas Teufel, Peter H. Krammer, Joseph T. Opferman, Marcus Schuchmann, Peter R. Galle, Henning Schulze‐Bergkamen	125
19	Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients 2006 ·World Journal of Gastroenterology ·Andreas Teufel	17
20	Positive energy bound states in resonating group calculations 1974 ·Physics Letters B ·David Clément, Erich W. Schmid, Andreas Teufel	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact